1989
DOI: 10.1097/00007611-198907000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Carpal Tunnel Syndrome With Vitamin B6 A Double-Blind Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0
4

Year Published

1999
1999
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(17 citation statements)
references
References 0 publications
0
13
0
4
Order By: Relevance
“…Stransky [40] clinical and electrophysiological CTS (1) pyridoxine 200 mg/day for 10 weeks Improvement in symptoms in 50 % (2), 80 % (n = 6 patients) (2) and 75 % (3) after 10 weeks, but no (2) placebo tablets (n = 5 patients) significant differences between the groups. because some patients received extra injections, and the moment of outcome assessment for them was different to that for patients who received no additional treatment.…”
Section: Pyridoxinementioning
confidence: 99%
See 1 more Smart Citation
“…Stransky [40] clinical and electrophysiological CTS (1) pyridoxine 200 mg/day for 10 weeks Improvement in symptoms in 50 % (2), 80 % (n = 6 patients) (2) and 75 % (3) after 10 weeks, but no (2) placebo tablets (n = 5 patients) significant differences between the groups. because some patients received extra injections, and the moment of outcome assessment for them was different to that for patients who received no additional treatment.…”
Section: Pyridoxinementioning
confidence: 99%
“…In 1 high quality [39] and 1 low quality [40] RCT the effect of pyridoxine was evaluated. Neither study found any significant differences in symptom improvement between the treatment groups, indicating moderate evidence (level 2) that pyridoxine and placebo are equally effective.…”
Section: Pyridoxinementioning
confidence: 99%
“…The most commonly used outcome measures were those related to symptoms of CTS. A wide variety of those measures were used including the following: specific descriptions of symptoms (eg, pain, paraesthesias), 11,13 more general expressions (eg, night discomfort or just symptoms), 10,14 combinations of symptoms (eg, night/day pain/paraesthesias, global symptom score), 13,16,18 measures relating to improvement of symptoms (eg, symptoms improved/changed/worsened), 15 or severity of symptoms (eg, main complaints: no complaints at all [0] to the most intense complaints I can imagine [10]). 12 Because pooling of heterogeneous outcomes will lead to an uninterpretable and misleading pooled estimate, meta-analysis is not feasible.…”
Section: Resultsmentioning
confidence: 99%
“…Vitamin B6'nın konservatif KTS tedavisinde herhangi bir avantaj sağlamadığı sonucuna varılmıştır (26). Bizim olgularımızda vitamin-B kompleksi verilen grupta FDS, SŞS ve VAS değerlerinde anlamlı iyileşme saptandı.…”
Section: Yöntemlerunclassified